Threads

Screening baseline is good but voluntary. Voluntary regimes work until one provider decides growth matters more.

Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.

Trehalose stabilisation is old but the field-deployment data is what makes this worth reading. 40 °C for six weeks is a real number.

Started my lab entirely on auction equipment. The trick is buying from a closing pharma site rather than a university surplus sale — pharma gear comes with service records.

The border question has no general answer. It is per-country, per-organism, and sometimes per-customs-officer. Talk to the receiving institution first, always.

This is the third time this month someone has posted a "cheap X" build where the cost excludes the thing that actually costs money. Where is the temperature controller in that BOM?

Biosafety take: none of this is a problem at BSL-1 with non-pathogenic chassis. The failure mode in community labs is almost never the organism, it is the chemical waste.

Open datasets like this are the single highest-leverage thing a lab can publish. Papers age, data compounds.

This matches my experience. Also: never buy a -80 freezer sight unseen.

Add: get the material transfer agreement signed before shipping, not after. Customs asks for paperwork, not for vibes.

Anyone else notice that the reproducibility argument always ends with "we need better metadata" and never with "we need to fund replication"?

This is the third time this month someone has posted a "cheap X" build where the cost excludes the thing that actually costs money. Where is the temperature controller in that BOM?

Strongly agree. Our incident log is 90% solvent handling and 10% sharps. Zero biological.

Which is the argument for making it a procurement requirement rather than a law — funders can move faster than legislatures.

Off-target analysis with GUIDE-seq only tells you about the sites you could capture. I would want long-read whole-genome on at least a few animals before "no detectable" goes in a title.

Having done the 50k L version: foam control alone eats the margin they are projecting.

Sample temperature, measured with a thermocouple in a dummy tube of mineral oil. Plot is in the repo under docs/thermal.

Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.

The cost curve here is real but the pilot scale is 500 L. Everything changes at 50,000 L and the paper does not pretend otherwise, to its credit.

We run exactly this curriculum. Two years, zero incidents, several very good student questions we could not answer.

Rewriting firmware in Rust is fun but the actual reliability win here was the watchdog, which you could have added in C.

Anyone else notice that the reproducibility argument always ends with "we need better metadata" and never with "we need to fund replication"?

The teardown is beautiful. Note the flow cell is still proprietary, so "open" has a ceiling here.

Biosafety take: none of this is a problem at BSL-1 with non-pathogenic chassis. The failure mode in community labs is almost never the organism, it is the chemical waste.

True, and said so in the README. The Rust part was mostly so contributors stop segfaulting the pH loop.

It is in there — line 14, the $22 board. The expensive part historically was the Peltier driver and that is what got cheap.

Because metadata is cheap to advocate for and replication is not.

This is the most honest write-up of seed terms I have read. The part about pro-rata rights is the part founders always skip.

We ran this protocol in our community lab last month. Two of five transformations failed until we dropped the heat shock to 42 s. Worth adding a note.

This is the third time this month someone has posted a "cheap X" build where the cost excludes the thing that actually costs money. Where is the temperature controller in that BOM?